Pinnacle Medicines | $89,000,000 | (Mar 27, 2026)
CurrentClient | $1,250,000 | (Mar 27, 2026)
Mirage | $75,000,000 | (Mar 27, 2026)
Certified by Founder
Lodge
ecovia I bio
start up
United States
- Ann Arbor, Michigan
- 04/02/2026
- Series B
- Undisclosed Amount
Ecovia Renewables Inc. was formed in 2014 as a spin-out company from the University of Michigan. It is our mission to develop and commercialize high-performing biobased ingredients and materials from sustainable processes at the best value for our customers. We do this by having microbial ecosystems work for us.
Our suite of Ecovia™ Biopolymers are created from a proprietary fermentation process. They are affordable, biobased, biodegradable, and functional alternatives to conventional acrylate and acrylamide polymers and starch-based biopolymers.
Applications range from soil additives for water retention to super-absorbent cores for infant diapers to thickeners for personal care and industrial products, among many others.
- Industry Biotechnology
- Website https://ecovia-bio.com/
- LinkedIn https://www.linkedin.com/company/ecovia-renewables/
Scalvy | $13,900,000 | (Mar 27, 2026)
SIGMAS | $1,000,000 | (Mar 27, 2026)
VITL | $7,500,000 | (Mar 27, 2026)
Payy | $6,000,000 | (Mar 27, 2026)
Conntour | $7,000,000 | (Mar 27, 2026)
KilgourMD | Undisclosed Amount | (Mar 27, 2026)
Terrestrial | $50,000,000 | (Mar 27, 2026)
Krane | $9,000,000 | (Mar 26, 2026)
Zalos (YC F25) | $3,600,000 | (Mar 26, 2026)